Twist Bioscience IPO: What Investors Need to Know

When the DNA sequencing industry splashed onto the scene 20 years ago, it took a special kind of crazy to predict that multibillion-dollar companies would emerge. The cost of reading a single human genome was over $1 billion, and there was little value to be gained from knowing a person's genetic sequence at the time.